naproxen has been researched along with Kidney Diseases in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (28.57) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A; Tam, KY | 1 |
| Bao, W; Berger, MF; Borer, JS; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Menon, V; Nissen, SE; Solomon, DH; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND | 1 |
| Angiolillo, DJ; Davidson, MH; Kloner, RA; White, WB | 1 |
| Bao, W; Beckerman, B; Berger, MF; Borer, JS; Gaffney, M; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Menon, V; Nissen, SE; Ruschitzka, F; Solomon, DH; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND | 1 |
| Khan, KN; Sellers, RS; Senese, PB | 1 |
| Campbell, MS; Makar, GA | 1 |
| Burnier, M; Mathieu, C; Meier, P; Meyer zu Starten, A | 1 |
| Carone, FA; Jarrett, MP; Kanwar, YS; Krumlovsky, FA; Quigley, MR; Richfield, M | 1 |
| Anttila, M; Haataja, M; Kasanen, A | 1 |
| Baslamisli, F; Kocak, R; Paydas, S; Tetiker, T | 1 |
| de Jong, PE; de Zeeuw, D; Haas, M; Kluppel, AC; Meijer, DK; Moolenaar, F; Wartna, ES | 1 |
| Tive, L | 1 |
| Deray, G | 1 |
| Basch, CM; Robinson, DR; Simon, LS; Young, DY | 1 |
| Freer, JP; Morris, ME; Watson, WA | 1 |
| Bourke, E; Campbell, WG; Delaney, VB; Ling, BN | 1 |
| Eriksson, LO; Sturfelt, G; Thysell, H; Wollheim, FA | 1 |
| Paulus, HE; Schlegel, SI | 1 |
| Almog, C; Bar, M; Burke, M; Isakov, A | 1 |
| Basch, C; Freer, JP; Katz, RS; Watson, WA | 1 |
| Catalano, MA | 1 |
5 review(s) available for naproxen and Kidney Diseases
| Article | Year |
|---|---|
Cardiorenal Safety of OTC Analgesics.
Topics: Acetaminophen; Analgesics; Drug Labeling; Heart Diseases; Humans; Ibuprofen; Kidney Diseases; Naproxen; Nonprescription Drugs; Patient Safety; Risk Assessment; Risk Factors | 2018 |
[Do selective COX-2 inhibitors have adverse renal and cardiovascular effects?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Kidney Diseases; Naproxen; Pyrazoles; Risk Assessment; Sulfonamides; Thromboembolism | 2005 |
Celecoxib clinical profile.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Humans; Ibuprofen; In Vitro Techniques; Isoenzymes; Kidney Diseases; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis; Pain; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome | 2000 |
Naproxen-induced nephropathy in systemic lupus erythematosus.
Topics: Acute Kidney Injury; Adult; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney Diseases; Lupus Erythematosus, Systemic; Naproxen; Nephritis, Interstitial; Nephrotic Syndrome; Proteinuria | 1990 |
Non-steroidal and analgesic therapy in the elderly.
Topics: Acetaminophen; Aged; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents; Apazone; Aspirin; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Diclofenac; Drug Hypersensitivity; Gastrointestinal Diseases; Hematologic Diseases; Humans; Ibuprofen; Indomethacin; Ketoprofen; Kidney Diseases; Kinetics; Naproxen; Phenylbutazone; Piroxicam; Salicylates; Thiazines | 1986 |
7 trial(s) available for naproxen and Kidney Diseases
| Article | Year |
|---|---|
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Celecoxib; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Kidney Diseases; Male; Middle Aged; Naproxen; Osteoarthritis; Risk Factors; Treatment Outcome | 2018 |
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Intention to Treat Analysis; Kidney Diseases; Male; Middle Aged; Naproxen; Risk | 2016 |
Comparison of effect of an anti-inflammatory drug and a narcotic analgesic on renal function in sickle cell anemia.
Topics: Adolescent; Adult; Analgesics, Opioid; Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Codeine; Humans; Kidney Diseases; Kidney Function Tests; Naproxen | 1996 |
Effects of naproxen on renal function in older patients with mild to moderate renal dysfunction.
Topics: Aged; Aging; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Creatine; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Hemodynamics; Humans; Kidney; Kidney Diseases; Middle Aged; Naproxen; Prostaglandins F; Thromboxane B2 | 1992 |
Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arthritis, Rheumatoid; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Naproxen; Placebos; Potassium; Renal Circulation; Renin; Sodium; Sulindac | 1990 |
Kidney function during naproxen therapy in patients at risk for renal insufficiency.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Naproxen; Random Allocation | 1988 |
Worldwide safety experience with diclofenac.
Topics: Adult; Aged; Aspirin; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Female; Gastrointestinal Diseases; Gastroscopy; Humans; Ibuprofen; Kidney Diseases; Middle Aged; Naproxen; Occult Blood; Piroxicam; Thiazines | 1986 |
9 other study(ies) available for naproxen and Kidney Diseases
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Interspecies differences in the nephrotoxic response to cyclooxygenase inhibition.
Topics: Animals; Area Under Curve; Cyclooxygenase Inhibitors; Dogs; Female; Kidney Diseases; Kidney Function Tests; Macaca fascicularis; Male; Naproxen; Species Specificity | 2004 |
Safety of short-term administration of celecoxib in decompensated cirrhosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Humans; Kidney Diseases; Liver Cirrhosis; Naproxen; Pyrazoles; Sulfonamides; Treatment Outcome | 2005 |
Concurrent naproxen- and penicillamine-induced renal disease in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Female; Glomerulonephritis; Humans; Kidney Diseases; Naproxen; Nephritis, Interstitial; Penicillamine; Proteinuria | 1982 |
Pharmacokinetics of naproxen in subjects with normal and impaired renal function.
Topics: Adult; Aged; Biotransformation; Creatinine; Female; Half-Life; Humans; Kidney Diseases; Kinetics; Male; Middle Aged; Naproxen; Protein Binding | 1980 |
Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Female; Iodine Radioisotopes; Kidney Diseases; Kidney Tubules, Proximal; Kinetics; Male; Muramidase; Naproxen; Rats; Rats, Wistar; Tissue Distribution | 1997 |
[Renal tolerance of selective inhibitors of cyclooxygenase type 2].
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Celecoxib; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Diclofenac; Humans; Kidney; Kidney Diseases; Lactones; Naproxen; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Rats; Risk Factors; Sulfonamides; Sulfones; Water-Electrolyte Imbalance | 2001 |
Sulfate homeostasis. III. Effect of chronic naproxen or sulindac treatment on inorganic sulfate disposition in arthritic patients with renal impairment.
Topics: Aged; Arthritis; Creatinine; Female; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Naproxen; Sulfates; Sulindac | 1991 |
Reversible, nonoliguric acute renal failure in a patient with rheumatoid arthritis and renal amyloidosis.
Topics: Acute Kidney Injury; Aged; Amyloidosis; Arthritis, Rheumatoid; Female; Humans; Kidney Diseases; Naproxen | 1986 |